IRIDEX Corporation (IRIX)

Market Cap	16.32M -2.8%
Revenue (ttm)	52.68M +8.2%
Net Income	-4.44M
EPS	-0.26
Shares Out	17.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	187,692
Open	1.0100
Previous Close	1.0100
Day's Range	0.9496 - 1.0300
52-Week Range	0.7900 - 1.6480
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In fiscal year 2025, IRIDEX's revenue was $52.68 million, an increase of 8.23% compared to the previous year's $48.67 million. Losses were -$4.44 million, -50.20% less than in 2024.